Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By activating these https://saadqjsz555836.thezenweb.com/setmelanotide-a-promising-new-treatment-for-obesity-74294293